Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Chiara Salviani, Francesco Scolari, Federico Alberici
Topics & Concepts
MedicineImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCohortAntibodyCoronavirus disease 2019 (COVID-19)Antibody responseVirologyInternal medicineDiseaseInfectious disease (medical specialty)Heparin-Induced Thrombocytopenia and ThrombosisSARS-CoV-2 and COVID-19 ResearchSystemic Lupus Erythematosus Research